imipenem, anhydrous has been researched along with Seizures in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (20.75) | 18.7374 |
1990's | 24 (45.28) | 18.2507 |
2000's | 11 (20.75) | 29.6817 |
2010's | 6 (11.32) | 24.3611 |
2020's | 1 (1.89) | 2.80 |
Authors | Studies |
---|---|
Bermingham, A; Blais, J; Capka, V; Cariaga, T; Casarez, A; Colvin, R; Dean, CR; Fekete, A; Gong, W; Growcott, E; Guo, H; Jones, AK; Li, C; Li, F; Lin, X; Lindvall, M; Lopez, S; McKenney, D; Metzger, L; Moser, HE; Prathapam, R; Rasper, D; Reck, F; Rudewicz, P; Sethuraman, V; Shaul, J; Shen, X; Simmons, RL; Tang, D; Tashiro, K; Tjandra, M; Turner, N; Uehara, T; Vitt, C; Whitebread, S; Yifru, A; Zang, X; Zhu, Q | 1 |
Caroline, C; Chien-Boon Lye, D; Choon-Kiat Tan, N; Ding, YY; Hsien-Xiong Lee, R; Lim, JP; Neo, HY; Pei-Ying Ho, E; Tan, KT; Wei-Han Ng, D | 1 |
Benjamin, DK; Capparelli, EV; Clark, RH; Cohen-Wolkowiez, M; Herring, AH; Hornik, CP; Kearns, GL; Smith, PB; van den Anker, J | 1 |
Cannon, JP; Clark, NM; Grim, SA; Lee, TA; Setlak, P | 1 |
Chen, K; Shi, Z; Wang, Q; Wu, Y | 1 |
Rüegg, S; Sutter, R; Tschudin-Sutter, S | 1 |
Galante, D | 1 |
Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P | 1 |
Kurata, Y; Kurosawa, T; Nawa, T; Shibasaki, S; Suzuki, H; Yagi, Y | 1 |
Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H | 1 |
Fukuda, H; Kawamura, Y | 1 |
Lovic, OS; Susic, V; Zivanovic, D | 1 |
Stanojlovic, O; Stojanovic, J; Susic, V; Zivanovic, D | 2 |
Ammendola, D; De Sarro, A; De Sarro, G; Nava, F | 1 |
Day, IP; Goudie, J; Nishiki, K; Williams, PD | 1 |
Matsumura, H; Nouda, H; Sumita, Y; Sunagawa, M | 1 |
Ammendola, D; De Sarro, A; De Sarro, G | 1 |
Caldwell, JW; Fink, MP; Heard, SO; Johnson, RH; Leeper, KV; Niederman, MS; Schentag, JJ; Siami, GA; Snydman, DR; Wunderink, RG | 1 |
Burke, JP; Classen, DC; Evans, RS; Pestotnik, SL; Stevens, LE | 1 |
Bianchi Llave, JL; Duro Ruiz, G; López-Gómez, M; Mediavilla García, JD | 1 |
Kania, D; Lane, M; Rapp, RP | 1 |
Guglielmo, BJ; Jacobs, RA | 1 |
Norrby, SR | 2 |
Campise, M | 1 |
Schranz, J | 1 |
Imamura, H; Jona, H; Kiyonaga, H; Moriya, M; Nakagawa, S; Nakano, M; Ohtake, N; Sato, H; Shimizu, A; Ushijima, R | 1 |
Hunter, WJ | 1 |
Gildon, KM; Norrby, SR | 1 |
Cho, JH; Jin, C; Jung, I; Kim, DH; Kim, M; Ku, HJ; Oh, CH; Yook, J | 1 |
Turhal, NS | 1 |
Bouquet, S; Couet, W; Dupuis, A; Limosin, A; Mimoz, O; Paquereau, J | 1 |
Salaria, M | 1 |
Daras, M; Hauser, WA; Koppel, BS; Politis, C; van Duin, D | 1 |
Fukasawa, M; Matsumura, H; Sunagawa, M | 1 |
Hill, EM; McCarthy, ID; Mostow, SR; Newcomb, HW | 1 |
Allen, N; Semel, JD | 1 |
Ballow, CH; Leo, RJ | 1 |
Inderlied, CB; Kim, KS; Mason, WH; Ross, LA; Wong, VK; Wright, HT | 1 |
Dretler, RH; Job, ML | 1 |
Brown, RB; Morris, AB; Sands, M | 1 |
Chmel, H; Eng, RH; Munsif, AN; Smith, SM; Yangco, BG | 1 |
Eguchi, T; Fujishita, M; Kataoka, R; Kotani, S; Miyagi, T; Miyoshi, I; Taguchi, H; Takeuchi, T | 1 |
Giles, RE; Patel, JB | 1 |
Haruta, T; Kobayashi, Y; Kubo, K; Kuroki, S; Okura, KE; Yamamoto, H; Yamaoka, K | 1 |
May, G | 1 |
Schliamser, SE | 1 |
Calandra, G; Carrigan, J; Guess, H; Lydick, E; Weiss, L | 1 |
Bennett, DB; Comereski, CR; Williams, PD | 1 |
Park, SY; Parker, RH | 1 |
Ahonkhai, VI; Aziz, MA; Brown, KR; Calandra, GB; Grad, LC; Wang, C | 1 |
Alexander, JW; Fant, WK; Rivera, JO; Solomkin, JS | 1 |
8 review(s) available for imipenem, anhydrous and Seizures
Article | Year |
---|---|
The risk of seizures among the carbapenems: a meta-analysis.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Meropenem; Risk; Seizures; Thienamycins | 2014 |
Seizures as adverse events of antibiotic drugs: A systematic review.
Topics: Animals; Anti-Bacterial Agents; Central Nervous System; Cephalosporins; Humans; Imipenem; Risk; Seizures | 2015 |
Neurotoxicity of carbapenem antibacterials.
Topics: Animals; Carbapenems; Child; Cilastatin; Humans; Imipenem; Meropenem; Receptors, GABA; Seizures; Thienamycins | 1996 |
Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Clindamycin; Diarrhea; Drug Eruptions; Humans; Imipenem; Meningitis; Meropenem; Nausea; Seizures; Thienamycins; Thrombocytosis | 1999 |
Carbapenems in serious infections: a risk-benefit assessment.
Topics: Adult; Cephalosporins; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Tolerance; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Risk Assessment; Seizures; Thienamycins | 2000 |
Imipenem.
Topics: Adolescent; Child; Child, Preschool; Cross Infection; Exanthema; Humans; Imipenem; Infant; Seizures; Thienamycins | 2001 |
Topics in clinical pharmacology: imipenem, a new broad spectrum antibiotic.
Topics: Humans; Imipenem; Seizures | 1988 |
Review of imipenem.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Seizures; Thienamycins | 1986 |
5 trial(s) available for imipenem, anhydrous and Seizures
Article | Year |
---|---|
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis; Seizures | 1994 |
Imipenem/cilastatin treatment of bacterial meningitis in children.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infant; Male; Meningitis; Meningitis, Haemophilus; Meningitis, Meningococcal; Retrospective Studies; Seizures | 1991 |
Seizure propensity with imipenem.
Topics: Aged; Aged, 80 and over; Animals; Cefotaxime; Female; Humans; Imipenem; Male; Mice; Middle Aged; Multicenter Studies as Topic; Penicillin G; Seizures | 1989 |
Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Central Nervous System Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Kidney Function Tests; Male; Regression Analysis; Retrospective Studies; Risk Factors; Seizures; Thienamycins; Time Factors; United States | 1988 |
Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
Topics: Adult; Aged; Bacterial Infections; Cilastatin; Clindamycin; Clinical Trials as Topic; Creatinine; Cyclopropanes; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation; Seizures; Thienamycins | 1985 |
40 other study(ies) available for imipenem, anhydrous and Seizures
Article | Year |
---|---|
Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; CHO Cells; Cricetulus; Drug Stability; Escherichia coli; Female; Humans; Meropenem; Mice; Microbial Sensitivity Tests; Molecular Structure; Monobactams; Pseudomonas aeruginosa; Receptors, GABA-A; Seizures; Structure-Activity Relationship; Thienamycins | 2018 |
Higher rates of carbapenem-related seizures in older hospitalised adults.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Logistic Models; Male; Meropenem; Seizures; Singapore | 2020 |
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Imipenem; Incidence; Infant; Intensive Care, Neonatal; Meropenem; Retrospective Studies; Seizures; Survival Analysis; Thienamycins | 2013 |
A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Incidence; Male; Meropenem; Middle Aged; Retrospective Studies; Seizures; Thienamycins; Young Adult | 2014 |
An unusual cause of seizures during subarachnoid anesthesia in a patient undergoing transurethral resection of the prostate: a case report.
Topics: Aged; Anesthesia, Spinal; Anesthetics, Local; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Diagnosis, Differential; Humans; Imipenem; Intraoperative Complications; Male; Preanesthetic Medication; Prostatic Hyperplasia; Seizures; Subarachnoid Space; Transurethral Resection of Prostate | 2009 |
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors | 2009 |
[Convulsive liability of an oral carbapenem antibiotic, tebipenem pivoxil].
Topics: Administration, Oral; Animals; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Imipenem; Infusions, Intravenous; Injections, Intraventricular; Male; Mice; Pentylenetetrazole; Rats; Seizures | 2009 |
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Hydrocephalus; Iatrogenic Disease; Imipenem; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Muscle Hypotonia; Seizures; Serratia Infections; Serratia marcescens; Spinal Puncture; Subdural Effusion; Tunisia | 2011 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
Effects of manipulation of N-methyl-D-aspartate receptors on imipenem/cilastatin-induced seizures in rats.
Topics: Acetamides; Animals; Binding Sites; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Electroencephalography; Imipenem; Male; Pyrrolidinones; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Valine | 2004 |
Induction of audiogenic seizures in imipenem/cilastatin-treated rats.
Topics: Animals; Anti-Bacterial Agents; Brain; Cilastatin; Dipeptidases; Drug Therapy, Combination; Electroencephalography; Imipenem; Injections, Intraventricular; Male; Motor Activity; Rats; Rats, Wistar; Seizures; Signal Processing, Computer-Assisted | 2004 |
The effects of phenytoin and phenobarbital on seizures induced by imipenem/cilastatin in rats.
Topics: Animals; Anticonvulsants; Cilastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Imipenem; Injections, Intraventricular; Male; Phenobarbital; Phenytoin; Prohibitins; Rats; Rats, Wistar; Seizures | 2004 |
Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Anticonvulsants; Dizocilpine Maleate; Excitatory Amino Acids; Glutamine; Imipenem; Kynurenic Acid; Mice; Mice, Inbred DBA; Muscimol; Piperazines; Piperidines; Quinoxalines; Seizures | 1995 |
Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem.
Topics: Analysis of Variance; Animals; Binding, Competitive; Cilastatin; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Imipenem; Injections, Intravenous; Male; Meropenem; Mice; Muscimol; Pentylenetetrazole; Rats; Receptors, GABA-A; Seizures; Thienamycins | 1995 |
Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain.
Topics: Animals; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Receptors, GABA; Seizures; Structure-Activity Relationship; Thienamycins | 1995 |
Effects of some quinolones on imipenem-induced seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Anti-Infective Agents; Drug Interactions; Electrocardiography; Imipenem; Injections, Intravenous; Lipids; Mice; Mice, Inbred DBA; Molecular Weight; Nalidixic Acid; Seizures; Species Specificity; Structure-Activity Relationship | 1994 |
Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Algorithms; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Pharmacy Information Systems; Drug Combinations; Female; Hospital Bed Capacity, 500 and over; Hospitals, University; Humans; Imipenem; Incidence; Length of Stay; Male; Middle Aged; Patient Admission; Population Surveillance; Prospective Studies; Seizures; Utah | 1993 |
[Convulsions induced by imipenem in an HIV-positive patient].
Topics: Adult; Female; HIV Seropositivity; Humans; Imipenem; Otitis Media, Suppurative; Pseudomonas Infections; Seizures; Thienamycins | 1995 |
Seizures related to use of imipenem-cilastatin.
Topics: Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Male; Middle Aged; Risk Factors; Seizures | 1996 |
Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Delivery Systems; Drug Monitoring; Drug Therapy, Combination; Humans; Imipenem; Risk Factors; Seizures | 1996 |
Neurological complication during imipenem/cilastatin therapy in uraemic patients.
Topics: Aged; Aged, 80 and over; Cilastatin; Confusion; Female; Humans; Imipenem; Male; Middle Aged; Nervous System; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Protease Inhibitors; Seizures; Thienamycins; Tremor; Uremia | 1998 |
Comparisons of seizure incidence and adverse experiences between imipenem and meropenem.
Topics: Animals; Drug Approval; Humans; Imipenem; Incidence; Meropenem; Seizures; Thienamycins; United States; United States Food and Drug Administration | 1998 |
Novel dithiocarbamate carbapenems with anti-MRSA activity.
Topics: Animals; Bacterial Proteins; Blood Proteins; Carbapenems; Carrier Proteins; Colony Count, Microbial; Dipeptidases; Hexosyltransferases; Humans; Imipenem; Kidney; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Rats; Seizures; Staphylococcus aureus; Structure-Activity Relationship; Swine; Thienamycins | 1998 |
Imipenem-induced seizure: a case of inappropriate, excessive, and prolonged surgical prophylaxis.
Topics: Aged; Drug Utilization Review; Humans; Imipenem; Male; Pharmacy Service, Hospital; Seizures; South Carolina | 1993 |
Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
Topics: Animals; Carbapenems; Cefazolin; Cephalosporins; GABA Agonists; Imipenem; Injections, Intraventricular; Male; Meropenem; Mice; Mice, Inbred ICR; Muscimol; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Synaptic Membranes; Thienamycins | 1999 |
Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Imipenem; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Seizures | 1999 |
Pharmacokinetic-pharmacodynamic modeling of electroencephalogram effect of imipenem in rats with acute renal failure.
Topics: Acute Kidney Injury; Animals; Electroencephalography; Imipenem; Kidney Function Tests; Male; Models, Biological; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Seizures; Thienamycins | 2001 |
Seizures in the critically ill: the role of imipenem.
Topics: Acute Disease; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Epilepsy; Hospital Records; Hospitalization; Humans; Imipenem; Incidence; Life Tables; Risk Factors; Seizures; Treatment Outcome | 2001 |
Structure-activity relationships of carbapenem and penem compounds for the convulsive property.
Topics: Animals; Anti-Bacterial Agents; Brain; Imipenem; Incidence; Injections, Intraventricular; Meropenem; Mice; Seizures; Structure-Activity Relationship; Thienamycins | 1992 |
Imipenem-cilastatin dosing intervention program by pharmacists.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Colorado; Drug Combinations; Hospital Bed Capacity, 300 to 499; Humans; Imipenem; Medication Errors; Pharmacists; Pharmacy Service, Hospital; Program Evaluation; Retrospective Studies; Risk Factors; Seizures | 1992 |
Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole.
Topics: Aged; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Monitoring, Physiologic; Seizures; Theophylline | 1991 |
Seizure activity associated with imipenem use: clinical case reports and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Seizures | 1991 |
Seizure activity with imipenem therapy: incidence and risk factors.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Humans; Imipenem; Joint Diseases; Knee Joint; Male; Pneumonia; Risk Factors; Seizures | 1990 |
Seizure propensity with imipenem.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Administration Schedule; Drug Combinations; Humans; Imipenem; Seizures | 1990 |
[Seizure and tremor occurring in acute leukemia patients treated with imipenem/cilastatin].
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Leukemia; Middle Aged; Seizures; Tremor | 1989 |
Meropenem: evidence of lack of proconvulsive tendency in mice.
Topics: Animals; Carbapenems; Cilastatin; Imipenem; Male; Meropenem; Mice; Seizures; Thienamycins | 1989 |
[Fundamental and clinical evaluation of imipenem/cilastatin sodium in the field of pediatrics].
Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Drug Eruptions; Female; Humans; Imipenem; Infant; Infusions, Intravenous; Male; Seizures; Thienamycins | 1986 |
Neurotoxicity of beta-lactam antibiotics. Experimental kinetic and neurophysiological studies.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Carbapenems; Cilastatin; Drug Interactions; Electroencephalography; Enterobacteriaceae Infections; Female; Hippocampus; Imipenem; Male; Meningitis; Penicillin G; Rabbits; Rats; Rats, Inbred Strains; Seizures; Thiopental; Tissue Distribution; Uremia | 1988 |
Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Disease Models, Animal; Drug Combinations; gamma-Aminobutyric Acid; Imipenem; Lactams; Male; Mice; Pentylenetetrazole; Seizures; Thienamycins | 1988 |
Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
Topics: Adolescent; Adult; Aged; Anaphylaxis; Cilastatin; Cyclopropanes; Digestive System; Drug Combinations; Drug Hypersensitivity; Humans; Imipenem; Liver; Middle Aged; Seizures; Thienamycins | 1985 |